TransMed is a leading provider of technology, insights, and expertise that help harness the power of knowledge to dramatically improve the process of developing, identifying, and matching eligible patients to clinical trials. Powered by a vast oncology data consortium, a powerful clinical trial enablement platform, and people expertise, TransMed believes that no time can be wasted in advancing the ability to bring promising and lasting solutions to cancer and other critical illnesses. Our expert team, in collaboration with our partners, customers and Scientific Advisory Board, is passionate about delivering the technology to use when life depends on it—and improving the standard or care for patients everywhere.